STAGE IV NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IV NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IV NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Ohio study aims to beat stage IV lung cancer with smarter drugs
Disease control Recruiting nowThis study looks at whether a special care plan called the Beating Lung Cancer in Ohio protocol can help people with stage IV non-small cell lung cancer live longer and feel better. It compares using targeted therapies and immunotherapies (which have fewer side effects than chemo…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:40 UTC
-
Supercharged immune cells take on hard-to-treat lung cancer
Disease control Recruiting nowThis early-phase study tests a special immune cell therapy (CD40L TIL) combined with the drug nivolumab for people with advanced non-small cell lung cancer that has specific gene changes (EGFR, ALK, ROS1, or HER2). The goal is to see if this treatment is safe and can shrink tumor…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 04:31 UTC
-
Blood test may guide smarter lung cancer therapy
Disease control Recruiting nowThis study tests whether a blood test (ctDNA) can help doctors decide if adding chemotherapy to the immunotherapy drug cemiplimab improves survival in people with advanced non-small cell lung cancer. About 63 adults with stage IV or stage IIIB/C lung cancer that has not been trea…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New program aims to ease emotional burden for advanced lung cancer patients
Symptom relief Recruiting nowThis study is testing a new supportive care program called POISE for people with stage IV non-small cell lung cancer who are on targeted therapy. The program includes four visits with a specially trained palliative care clinician to help patients cope with uncertainty and manage …
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 04:41 UTC